Prospective multicenter phase II study of gemcitabine plus cisplatin in patients with unresectable gallbladder cancer

被引：0
作者：
Yoshiki Hirooka
Takuya Ishikawa
Hiroki Kawashima
Eizaburo Ohno
Koji Nonogaki
Akira Kanamori
Takanori Hirai
Hiroki Uchida
Osamu Shirai
Hideki Ishikawa
Hidemi Goto
机构：
[1] Nagoya University Hospital,Department of Endoscopy
[2] Nagoya University Graduate School of Medicine,Department of Gastroenterology
[3] Daido Hospital,Department of Gastroenterology
[4] Ogaki Municipal Hospital,Department of Gastroenterology
[5] Komaki City Hospital,Department of Gastroenterology
[6] Okazaki City Hospital,Department of Gastroenterology
[7] Toki General Hospital,Department of Gastroenterology
[8] Tokai Central Hospital,Department of Gastroenterology
来源：
Cancer Chemotherapy and Pharmacology | 2017年 / 80卷
关键词：
Gemcitabine; Cisplatin; Gallbladder cancer; Unresectable; Prospective study; Multicenter;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：119 / 125
页数：6
相关论文
共 50 条
[21]   A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer [J].
Oh, Do-Youn ;
Cha, Yongjun ;
Choi, In-Sil ;
Yoon, So-Young ;
Choi, In Keun ;
Kim, Jee Hyun ;
Oh, Sang Cheul ;
Kim, Chang Duck ;
Kim, Jae Sun ;
Bang, Yung-Jue ;
Kim, Yeul Hong .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (03) :527-536
[22]   A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer [J].
Do-Youn Oh ;
Yongjun Cha ;
In-Sil Choi ;
So-Young Yoon ;
In Keun Choi ;
Jee Hyun Kim ;
Sang Cheul Oh ;
Chang Duck Kim ;
Jae Sun Kim ;
Yung-Jue Bang ;
Yeul Hong Kim .
Cancer Chemotherapy and Pharmacology, 2010, 65 :527-536
[23]   A multicenter, randomized, phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma [J].
De Marinis, F ;
Nelli, F ;
Lombardo, M ;
Ferraú, F ;
Barbera, S ;
Bertetto, O ;
Barni, S ;
Michetti, G ;
Labianca, R ;
Gridelli, C .
CANCER, 2005, 103 (04) :772-779
[24]   Phase II study of gemcitabine and cisplatin in chemonaive patients with advanced epithelial ovarian cancer [J].
Nogué, M ;
Cirera, L ;
Arcusa, A ;
Batiste-Alentorn, E ;
Balil, A ;
Font, A ;
Perez-Gracia, JL ;
Carrasco, EM ;
Tusquets, I .
ANTI-CANCER DRUGS, 2002, 13 (08) :839-845
[25]   Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study [J].
Alexander R. Siebenhüner ;
Heike Seifert ;
Helga Bachmann ;
Burkhardt Seifert ;
Thomas Winder ;
Jonas Feilchenfeldt ;
Stefan Breitenstein ;
Pierre-Alain Clavien ;
Roger Stupp ;
Alexander Knuth ;
Bernhard Pestalozzi ;
Panagiotis Samaras .
BMC Cancer, 18
[26]   Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study [J].
Siebenhuener, Alexander R. ;
Seifert, Heike ;
Bachmann, Helga ;
Seifert, Burkhardt ;
Winder, Thomas ;
Feilchenfeldt, Jonas ;
Breitenstein, Stefan ;
Clavien, Pierre-Alain ;
Stupp, Roger ;
Knuth, Alexander ;
Pestalozzi, Bernhard ;
Samaras, Panagiotis .
BMC CANCER, 2018, 18
[27]   A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202 [J].
Iqbal, Syma ;
Rankin, Cathryn ;
Lenz, Heinz-Josef ;
Gold, Philip J. ;
Ahmad, Syed A. ;
El-Khoueiry, Anthony B. ;
Messino, Michael J. ;
Holcombe, Randall F. ;
Blanke, Charles D. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (06) :1595-1602
[28]   A phase II study of gemcitabine in gallbladder carcinoma [J].
Gallardo, JO ;
Rubio, B ;
Fodor, M ;
Orlandi, L ;
Yáñez, M ;
Gamargo, C ;
Ahumada, M .
ANNALS OF ONCOLOGY, 2001, 12 (10) :1403-1406
[29]   Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer [J].
R D Kim ;
S R Alberts ;
C Peña ;
I Genvresse ;
A Ajavon-Hartmann ;
C Xia ;
A Kelly ;
J E Grilley-Olson .
British Journal of Cancer, 2018, 118 :462-470
[30]   Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer [J].
Kim, R. D. ;
Alberts, S. R. ;
Pena, C. ;
Genvresse, I. ;
Ajavon-Hartmann, A. ;
Xia, C. ;
Kelly, A. ;
Grilley-Olson, J. E. .
BRITISH JOURNAL OF CANCER, 2018, 118 (04) :462-470
12345